|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Available for sale securities, at fair value, net of allowance for credit losses | ||||||||||||||||||||
| Loans, at fair value | ||||||||||||||||||||
| Equity securities | ||||||||||||||||||||
| Other investments | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Notes and accounts receivable, net | ||||||||||||||||||||
| Reinsurance recoverable | ||||||||||||||||||||
| Total prepaid reinsurance premiums | ||||||||||||||||||||
| Deferred acquisition costs | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Marketable securities | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Right of use asset | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders’ Equity | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Debt, net | ||||||||||||||||||||
| Unearned premiums | ||||||||||||||||||||
| Policy liabilities and unpaid claims | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Reinsurance payable | ||||||||||||||||||||
| Other liabilities and accrued expenses | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Short-term debt, net | ||||||||||||||||||||
| Current tax payable | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt, net | ||||||||||||||||||||
| Long-term lease obligations | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Liabilities held for sale | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ Equity: | ||||||||||||||||||||
| Preferred stock: $0.001 par value, 100,000,000 shares authorized, none issued or outstanding | ||||||||||||||||||||
| Common stock: $0.001 par value, 200,000,000 shares authorized, 37,266,005 and 37,824,472 shares issued and outstanding, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income (loss), net of tax | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total Tiptree Inc, stockholders' equity | ||||||||||||||||||||
| Non-controlling interests | ||||||||||||||||||||
| Fortegra preferred interests | ||||||||||||||||||||
| Common interests | ||||||||||||||||||||
| Total non-controlling interests | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...